Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Tzu Tai

Showing results (61-70 of 211) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2008
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myelomaMasahisa Jinushi, Matthew Vanneman, Nikhil C Munshi, et al.
Blood|May 27, 2006
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cellsLaurence Catley, Ellen Weisberg, Tanyel Kiziltepe, et al.
Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in ChinaTengteng Yu, Yan Xu, Gang An, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cellJooeun Bae, Constantine Mitsiades, Yu-Tzu Tai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2024
Retraction: Ku86 Variant Expression and Function in Multiple Myeloma Cells Is Associated with Increased Sensitivity to DNA DamageYu-Tzu Tai, Gerrard Teoh, Boris Lin, et al.
Leukemia|July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myelomaJooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.
Blood|October 7, 2006
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl)Klaus Podar, Marc S Raab, Jing Zhang, et al.
British Journal of Haematology|April 27, 2012
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agentsMerav Leiba, Jana Jakubikova, Steffen Klippel, et al.
British Journal of Haematology|November 25, 2003
Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survivalRenate Burger, Frank Bakker, Andreas Guenther, et al.
Pageof 22

Showing results (61-70 of 211) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2008
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myelomaMasahisa Jinushi, Matthew Vanneman, Nikhil C Munshi, et al.
Blood|May 27, 2006
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cellsLaurence Catley, Ellen Weisberg, Tanyel Kiziltepe, et al.
Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in ChinaTengteng Yu, Yan Xu, Gang An, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cellJooeun Bae, Constantine Mitsiades, Yu-Tzu Tai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2024
Retraction: Ku86 Variant Expression and Function in Multiple Myeloma Cells Is Associated with Increased Sensitivity to DNA DamageYu-Tzu Tai, Gerrard Teoh, Boris Lin, et al.
Leukemia|July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myelomaJooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.
Blood|October 7, 2006
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl)Klaus Podar, Marc S Raab, Jing Zhang, et al.
British Journal of Haematology|April 27, 2012
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agentsMerav Leiba, Jana Jakubikova, Steffen Klippel, et al.
British Journal of Haematology|November 25, 2003
Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survivalRenate Burger, Frank Bakker, Andreas Guenther, et al.
Pageof 22